The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Open accessAbstract
Breast cancer is the most common cancer and the deadliest among women worldwide. Estrogen signaling is closely associated with hormone-dependent breast cancer (estrogen and progesterone receptor positive), which accounts for two-thirds of tumors. Hormone therapy using antiestrogens is the gold standard, but resistance to these treatments invariably occurs through various biological mechanisms, such as changes in estrogen receptor activity, mutations in the ESR1 gene, aberrant activation of the PI3K pathway or cell cycle dysregulations. All these factors have led to the development of new therapies, such as selective estrogen receptor degraders (SERDs), or combination therapies with cyclin-dependent kinases (CDK) 4/6 or PI3K inhibitors. Therefore, understanding the estrogen pathway is essential for the treatment and new drug development of hormone-dependent cancers. This mini-review summarizes current literature on the signalization, mechanisms of action and clinical implications of estrogen receptors in breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
Breast Cancer Treatment: A Review
Waks, A. G., & Winer, E. P. (2019) · JAMA · doi:10.1001/jama.2018.19323 · Cited by 4,804
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Breast cancer statistics, 2019
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,114
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Risk Factors and Preventions of Breast Cancer
Sun, Y.-S., Zhao, Z., Yang, Z.-N., Xu, F., Lu, H.-J., Zhu, Z.-Y., Shi, W., Jiang, J., Yao, P.-P., & Zhu, H.-P. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21635 · Cited by 2,003
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
Garrido-Castro, A. C., Lin, N. U., & Polyak, K. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1177 · Cited by 1,451
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Björnström, L., & Sjöberg, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0486 · Cited by 1,362
Clinical implications of the intrinsic molecular subtypes of breast cancer
Prat, A., Pineda, E., Adamo, B., Galván, P., Fernández, A., Gaba, L., Díez, M., Viladot, M., Arance, A., & Muñoz, M. (2015) · The Breast · doi:10.1016/j.breast.2015.07.008 · Cited by 1,319
(2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70425-4 · Cited by 1,160
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
The 2019 World Health Organization classification of tumours of the breast
Tan, P. H., Ellis, I., Allison, K., Brogi, E., Fox, S. B., Lakhani, S., Lazar, A. J., Morris, E. A., Sahin, A., Salgado, R., et al. (2020) · Histopathology · doi:10.1111/his.14091 · Cited by 1,097
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Liang, Y., Zhang, H., Song, X., & Yang, Q. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.012 · Cited by 992
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
Overcoming Endocrine Resistance in Breast Cancer
Hanker, A. B., Sudhan, D. R., & Arteaga, C. L. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.009 · Cited by 927
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Organization and execution of the epithelial polarity programme
Rodriguez-Boulan, E., & Macara, I. G. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3775 · Cited by 693
Breast Cancer Epidemiology, Prevention, and Screening
Winters, S., Martin, C., Murphy, D., & Shokar, N. K. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.07.002 · Cited by 667
Rapid actions of plasma membrane estrogen receptors
Kelly, M. J., & Levin, E. R. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00377-0 · Cited by 643
Nguyen, B., Fong, C., Luthra, A., Smith, S. A., DiNatale, R. G., Nandakumar, S., Walch, H., Chatila, W. K., Madupuri, R., Kundra, R., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.003 · Cited by 623
Prat, A., Cheang, M. C. U., Martín, M., Parker, J. S., Carrasco, E., Caballero, R., Tyldesley, S., Gelmon, K., Bernard, P. S., Nielsen, T. O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4134 · Cited by 587
Baselga, J., Im, S.-A., Iwata, H., Cortés, J., De Laurentiis, M., Jiang, Z., Arteaga, C. L., Jonat, W., Clemons, M., Ito, Y., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30376-5 · Cited by 533
Patel, H. K., & Bihani, T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.012 · Cited by 499
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells
Castoria, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6050 · Cited by 468
Li, L., Haynes, M. P., & Bender, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831079100 · Cited by 465
Tremblay, A., Tremblay, G. B., Labrie, F., & Giguère, V. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80479-7 · Cited by 464
Epigenetic mechanisms in breast cancer therapy and resistance
Garcia-Martinez, L., Zhang, Y., Nakata, Y., Chan, H. L., & Morey, L. (2021) · Nature Communications · doi:10.1038/s41467-021-22024-3 · Cited by 458
Maggiolini, M., Vivacqua, A., Fasanella, G., Recchia, A. G., Sisci, D., Pezzi, V., Montanaro, D., Musti, A. M., Picard, D., & Andò, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403588200 · Cited by 448
Palmitoylation-dependent Estrogen Receptor α Membrane Localization: Regulation by 17β-Estradiol
Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, P., & Marino, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0547 · Cited by 438
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Font de Mora, J., & Brown, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5041-5047.2000 · Cited by 432
Flouriot, G. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4688 · Cited by 425
Self-citationAlbanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T. I., Prossnitz, E. R., Musti, A. M., Andò, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2909 · Cited by 399
Selective Estrogen Receptor Modulators
Frasor, J., Stossi, F., Danes, J. M., Komm, B., Lyttle, C. R., & Katzenellenbogen, B. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3326 · Cited by 395
Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., & Deuel, T. F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.226 · Cited by 392
The role of the insulin-like growth factor-1 system in breast cancer
Christopoulos, P. F., Msaouel, P., & Koutsilieris, M. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0291-7 · Cited by 376
Turner, N. C., Kingston, B., Kilburn, L. S., Kernaghan, S., Wardley, A. M., Macpherson, I. R., Baird, R. D., Roylance, R., Stephens, P., Oikonomidou, O., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30444-7 · Cited by 369
Regulation of Estrogen Rapid Signaling through Arginine Methylation by PRMT1
Le Romancer, M., Treilleux, I., Leconte, N., Robin-Lespinasse, Y., Sentis, S., Bouchekioua-Bouzaghou, K., Goddard, S., Gobert-Gosse, S., & Corbo, L. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.025 · Cited by 324
Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development
Ciarloni, L., Mallepell, S., & Brisken, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611647104 · Cited by 316
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
Le Romancer, M., Poulard, C., Cohen, P., Sentis, S., Renoir, J.-M., & Corbo, L. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0016 · Cited by 313
ESR1 mutations in breast cancer
Dustin, D., Gu, G., & Fuqua, S. A. W. (2019) · Cancer · doi:10.1002/cncr.32345 · Cited by 306
Curtis, S. W., Washburn, T., Sewall, C., DiAugustine, R., Lindzey, J., Couse, J. F., & Korach, K. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12626 · Cited by 304
Integration of the Non-genomic and Genomic Actions of Estrogen
Pedram, A., Razandi, M., Aitkenhead, M., Hughes, C. C. W., & Levin, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210106200 · Cited by 293
Becker, L. M., O’Connell, J. T., Vo, A. P., Cain, M. P., Tampe, D., Bizarro, L., Sugimoto, H., McGow, A. K., Asara, J. M., Lovisa, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107701 · Cited by 291
The double dealing of cyclin D1
Tchakarska, G., & Sola, B. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1706903 · Cited by 278
Jiang, Z., Li, W., Hu, X., Zhang, Q., Sun, T., Cui, S., Wang, S., Ouyang, Q., Yin, Y., Geng, C., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30164-0 · Cited by 270
Phosphorylation of Human Estrogen Receptor α by Protein Kinase A Regulates Dimerization
Chen, D., Pace, P. E., Coombes, R. C., & Ali, S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1002 · Cited by 260
BRCA1 and BRCA2 mutations and treatment strategies for breast cancer
Godet, I., & M. Gilkes, D. (2017) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000228 · Cited by 250
Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives
Barton, M., Filardo, E. J., Lolait, S. J., Thomas, P., Maggiolini, M., & Prossnitz, E. R. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.021 · Cited by 248
Cardoso, F., Bedard, P. L., Winer, E. P., Pagani, O., Senkus-Konefka, E., Fallowfield, L. J., Kyriakides, S., Costa, A., Cufer, T., Albain, K. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp235 · Cited by 241
Estrogen Receptors: New Directions in the New Millennium
Hewitt, S. C., & Korach, K. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00087 · Cited by 240
Breast Development and Anatomy
Pandya, S. V., & Moore, R. G. (2011) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e318207ffe9 · Cited by 227
Kim, M. Y., Woo, E. M., Chong, Y. T. E., Homenko, D. R., & Kraus, W. L. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0531 · Cited by 227
Shi, L., Dong, B., Li, Z., Lu, Y., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2254 · Cited by 226
MYC-Driven Pathways in Breast Cancer Subtypes
Fallah, Y., Brundage, J., Allegakoen, P., & Shajahan-Haq, A. N. (2017) · Biomolecules · doi:10.3390/biom7030053 · Cited by 226
Owman, C., Blay, P., Nilsson, C., & Lolait, S. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1654 · Cited by 224
Stender, J. D., Kim, K., Charn, T. H., Komm, B., Chang, K. C. N., Kraus, W. L., Benner, C., Glass, C. K., & Katzenellenbogen, B. S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00118-10 · Cited by 206
The Androgen Receptor in Breast Cancer
Giovannelli, P., Di Donato, M., Galasso, G., Di Zazzo, E., Bilancio, A., & Migliaccio, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00492 · Cited by 204
Environmental chemicals, breast cancer progression and drug resistance
Koual, M., Tomkiewicz, C., Cano-Sancho, G., Antignac, J.-P., Bats, A.-S., & Coumoul, X. (2020) · Environmental Health · doi:10.1186/s12940-020-00670-2 · Cited by 204
Girault, I., Lerebours, F., Amarir, S., Tozlu, S., Tubiana-Hulin, M., Lidereau, R., & Bièche, I. (2003) · PubMed · Cited by 193
Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer
Wang, Z.-Y., & Yin, L. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.017 · Cited by 183
Migliaccio, A., Di Domenico, M., Castoria, G., Nanayakkara, M., Lombardi, M., de Falco, A., Bilancio, A., Varricchio, L., Ciociola, A., & Auricchio, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0912 · Cited by 182
S-palmitoylation modulates human estrogen receptor-α functions
Acconcia, F., Ascenzi, P., Fabozzi, G., Visca, P., & Marino, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.129 · Cited by 180
Estrogen rapid action via protein complex formation involving ERα and Src
Song, R. X.-D., Zhang, Z., & Santen, R. J. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.06.010 · Cited by 177
Denger, S., Reid, G., Koš, M., Flouriot, G., Parsch, D., Brand, H., Korach, K. S., Sonntag-Buck, V., & Gannon, F. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0741 · Cited by 170
Self-citationA positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells
Zhang, X. T., Kang, L. G., Ding, L., Vranic, S., Gatalica, Z., & Wang, Z.-Y. (2011) · Oncogene · doi:10.1038/onc.2010.458 · Cited by 168
TP53 Mutations in Breast and Ovarian Cancer
Silwal-Pandit, L., Langerød, A., & Børresen-Dale, A.-L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026252 · Cited by 167
Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo?
Luo, J., & Liu, D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00148 · Cited by 167
Two Separate Mechanisms for Ligand-Independent Activation of the Estrogen Receptor
El-Tanani, M. K. K. (1997) · Molecular Endocrinology · doi:10.1210/me.11.7.928 · Cited by 165
Brufsky, A. M., & Dickler, M. N. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0423 · Cited by 165
ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance
Xu, Y., Huangyang, P., Wang, Y., Xue, L., Devericks, E., Nguyen, H. G., Yu, X., Oses-Prieto, J. A., Burlingame, A. L., Miglani, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.036 · Cited by 165
Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
Francesco, E. M. D., Maggiolini, M., & Musti, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072011 · Cited by 163
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity
Thomas, R. S., Sarwar, N., Phoenix, F. A., Coombes, R. C., & Ali, S. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0165 · Cited by 159
Yu, T., Yang, G., Hou, Y., Tang, X., Wu, C., Wu, X.-A., Guo, L., Zhu, Q., Luo, H., Du, Y.-E., et al. (2016) · Oncogene · doi:10.1038/onc.2016.370 · Cited by 153
Endocrine disruptors from the environment affecting breast cancer (Review)
Calaf, G. M., Ponce‐Cusi, R., Aguayo, F., Mu�oz, J., & Bleak, T. C. (2020) · Oncology Letters · doi:10.3892/ol.2020.11566 · Cited by 152
Arnold, S. F., Vorojeikina, D. P., & Notides, A. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30205 · Cited by 149
Wittmann, B. M., Sherk, A. B., & McDonnell, D. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1590 · Cited by 145
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
Mal, R., Magner, A., David, J., Datta, J., Vallabhaneni, M., Kassem, M. A. M., Manouchehri, J. M., Willingham, N., Stover, D. G., VanDeusen, J. B., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.587386 · Cited by 141
Complexities of androgen receptor signalling in breast cancer
McNamara, K. M., Moore, N. L. T., Hickey, T. E., Sasano, H., & Tilley, W. D. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0243 · Cited by 140
GPER Mediates Activation of HIF1α/VEGF Signaling by Estrogens
Francesco, E. M. D., PELLEGRINO, M. A., Santolla, M. F., Lappano, R., Ricchio, E., Abonante, S., & Maggiolini, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3590 · Cited by 135
Rosa, P. L., Pesiri, V., Leclercq, G., Marino, M., & Acconcia, F. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1208 · Cited by 130
The role of estrogen receptor beta in breast cancer
Zhou, Y., & Liu, X. (2020) · Biomarker Research · doi:10.1186/s40364-020-00223-2 · Cited by 130
Cabodi, S., Moro, L., Baj, G., Smeriglio, M., Stefano, P. D., Gippone, S., Surico, N., Silengo, L., Turco, E., Tarone, G., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01025 · Cited by 128
How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
Venkitaraman, A. R. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102668 · Cited by 126
Connolly, R. M., Zhao, F., Miller, K. D., Lee, M.-J., Piekarz, R. L., Smith, K. L., Brown-Glaberman, U. A., Winn, J. S., Faller, B. A., Onitilo, A. A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00944 · Cited by 125
GPER Function in Breast Cancer: An Overview
Lappano, R., Pisano, A., & Maggiolini, M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00066 · Cited by 125
Varricchio, L., Migliaccio, A., Castoria, G., Yamaguchi, H., de Falco, A., Domenico, M. D., Giovannelli, P., Farrar, W. L., Appella, E., & Auricchio, F. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0150 · Cited by 121
Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention
Slepicka, P. F., Cyrill, S. L., & dos Santos, C. O. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.06.003 · Cited by 121
Aromatase inhibitors: Role in postmenopausal breast cancer
Kharb, R., Haider, K., Neha, K., & Yar, M. S. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000081 · Cited by 117
Estrogen and Tamoxifen Induce Cytoskeletal Remodeling and Migration in Endometrial Cancer Cells
Acconcia, F., Barnes, C. J., & Kumar, R. (2005) · Endocrinology · doi:10.1210/en.2005-1293 · Cited by 116
Regulation of Mouse Mammary Gland Development and Tumorigenesis by the ERBB Signaling Network
Troyer, K. L., & Lee, D. C. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009560330359 · Cited by 114
Estrogen receptor-mediated cross-talk with growth factor signaling pathways
Kato, S. (2001) · Breast Cancer · doi:10.1007/bf02967472 · Cited by 112
Giovannelli, P., Donato, M. D., Auricchio, F., Castoria, G., & Migliaccio, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41016-4 · Cited by 111
The physiological role of estrogen receptor functional domains
Arao, Y., & Korach, K. S. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200167 · Cited by 109
Molina, L., Figueroa, C. D., Bhoola, K. D., & Ehrenfeld, P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1350264 · Cited by 108
Madak‐Erdogan, Z., Kim, S. H., Gong, P., Zhao, Y. C., Zhang, H., Chambliss, K. L., Carlson, K. E., Mayne, C. G., Shaul, P. W., Korach, K. S., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad8170 · Cited by 106
Serum testosterone levels and breast cancer recurrence
Berrino, F., Pasanisi, P., Bellati, C., Venturelli, E., Krogh, V., Mastroianni, A., Berselli, E., Muti, P. C., & Secreto, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20582 · Cited by 102
Activation of rapid oestrogen signalling in aggressive human breast cancers
Poulard, C., Treilleux, I., Lavergne, E., Bouchekioua‐Bouzaghou, K., Goddard‐Léon, S., Chabaud, S., Trédan, O., Corbo, L., & Romancer, M. L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201615 · Cited by 98
Catalano, S., Giordano, C., Panza, S., Chemi, F., Bonofiglio, D., Lanzino, M., Rizza, P., Romeo, F., Fuqua, S. A. W., Maggiolini, M., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3017-4 · Cited by 98
Vivacqua, A., Romeo, E., Marco, P. D., Francesco, E. M. D., Abonante, S., & Maggiolini, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1901-8 · Cited by 96
Emerging Estrogenic Pollutants in the Aquatic Environment and Breast Cancer
Lecomte, S., Habauzit, D., Charlier, T. D., & Pakdel, F. (2017) · Genes · doi:10.3390/genes8090229 · Cited by 92
Self-citationESR1 activating mutations: From structure to clinical application
Grinshpun, A., Chen, V. C., Sandusky, Z. M., Fanning, S. W., & Jeselsohn, R. M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188830 · Cited by 88
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Rusidzé, M., Adlanmérini, M., Chantalat, É., Raymond‐Letron, I., Cayre, S., Arnal, J., Deugnier, M., & Lenfant, F. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03860-4 · Cited by 82
Silveira, A. B., Bidard, F., Tanguy, M., Girard, E., Trédan, O., Dubot, C., Jacot, W., Gonçalvès, A., Debled, M., Lévy, C., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00319-4 · Cited by 82
Silva, E. A., Kabil, A., & Kortenkamp, A. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.02.015 · Cited by 81
Duplessis, T., Williams, C. C., Hill, S. M., & Rowan, B. G. (2011) · Endocrinology · doi:10.1210/en.2010-1281 · Cited by 75
Tomita, Y., Lee, M.-J., Lee, S., Tomita, S., Chumsri, S., Cruickshank, S., Ordentlich, P., & Trepel, J. B. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1219008 · Cited by 75
Fridriksdottir, A. J., Kim, J., Villadsen, R., Klitgaard, M. C., Hopkinson, B. M., Petersen, O. W., & Rønnov‐Jessen, L. (2015) · Nature Communications · doi:10.1038/ncomms9786 · Cited by 73
Kodahl, A. R., Ehmsen, S., Pallisgaard, N., Jylling, A. M. B., Jensen, J. D., Lænkholm, A., Knoop, A. S., & Ditzel, H. J. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12305 · Cited by 72
The role of histone deacetylase inhibitors in metastatic breast cancer
Zucchetti, B. M., Shimada, A. K., Katz, A., & Curigliano, G. (2018) · The Breast · doi:10.1016/j.breast.2018.12.001 · Cited by 72
A Role for Estrogen Receptor alpha36 in Cancer Progression
Pagano, M., Ortona, E., & Dupuis, M. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00506 · Cited by 72
Clusan, L., Goff, P. L., Flouriot, G., & Pakdel, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020756 · Cited by 69
Self-citationPTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer
Csolle, M. P., Ooms, L. M., Papa, A., & Mitchell, C. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239189 · Cited by 66
Bisi, J., Sorrentino, J. A., Jordan, J. L., Darr, D. D., Roberts, P. J., Tavares, F. X., & Strum, J. C. (2017) · Oncotarget · doi:10.18632/oncotarget.16216 · Cited by 65
Pellacani, D., Tan, S., Lefort, S., & Eaves, C. J. (2019) · The EMBO Journal · doi:10.15252/embj.2018100330 · Cited by 64
Madak‐Erdogan, Z., Ventrella, R., Petry, L. G., & Katzenellenbogen, B. S. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0588 · Cited by 60
Manoochehri, M., Borhani, N., Gerhäuser, C., Assenov, Y., Schönung, M., Hielscher, T., Christensen, B. C., Lee, M. K., Gröne, H., Lipka, D. B., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34337 · Cited by 58
Non-genomic signaling of steroid receptors in cancer
Thiébaut, C., Vlaeminck‐Guillem, V., Trédan, O., Poulard, C., & Romancer, M. L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111453 · Cited by 55
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
Choucair, A., Pham, T. H., Omarjee, S., Jacquemetton, J., Kassem, L. M. H., Trédan, O., Rambaud, J., Marangoni, E., Corbo, L., Treilleux, I., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0694-9 · Cited by 54
GPER‐induced signaling is essential for the survival of breast cancer stem cells
Chan, Y., Lai, A. C., Lin, R., Wang, Y., Wang, Y., Chang, W., Wu, H., Lin, Y., Chang, W., Wu, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32588 · Cited by 54
Lappano, R., & Maggiolini, M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.02.019 · Cited by 52
Rao, J., Jiang, X., Wang, Y., & Chen, B. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.08.004 · Cited by 51
Genua, M., Pandini, G., Sisci, D., Castoria, G., Maggiolini, M., Vigneri, R., & Belfiore, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0088 · Cited by 50
Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
Oronsky, B. T., Oronsky, N. C., Knox, S. J., Fanger, G. R., & Scicinski, J. J. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520614666140418144610 · Cited by 49
Praud, D., Deygas, F., Amadou, A., Bouilly, M., Turati, F., Bravi, F., Xu, T., Grassot, L., Coudon, T., & Fervers, B. (2023) · Cancers · doi:10.3390/cancers15030927 · Cited by 49
Non-canonical Estrogen Signaling in Endocrine Resistance
Ranganathan, P., Nadig, N., & Nambiar, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00708 · Cited by 48
Talia, M., Francesco, E. M. D., Rigiracciolo, D. C., Muoio, M. G., Muglia, L., Belfiore, A., Maggiolini, M., Sims, A. H., & Lappano, R. (2020) · Cells · doi:10.3390/cells9030622 · Cited by 48
Hormonal modulation of ESR1 mutant metastasis
Gu, G., Tian, L. H., Herzog, S. K., Rechoum, Y., Gelsomino, L., Gao, M., Du, L., Kim, J.-A., Dustin, D. J., Lo, H. C., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01563-x · Cited by 46
Xu, T., Ma, D., Chen, S., Tang, R., Yang, J., Meng, C.-H., Feng, Y., Liu, L., Wang, J., Luo, H., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00472-4 · Cited by 46
The Role of ERα36 in Development and Tumor Malignancy
Thiébaut, C., Konan, H.-P., Guerquin, M.-J., Chesnel, A., Livera, G., Romancer, M. L., & Dumond, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114116 · Cited by 45
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling
Steelman, L. S., Chappell, W. H., Akula, S. M., Abrams, S. L., Cocco, L., Manzoli, L., Ratti, S., Martelli, A. M., Montalto, G., Cervello, M., et al. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100758 · Cited by 44
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 44
Zhang, H., Wang, M., & Xu, Y. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0547 · Cited by 43
Breast cancer stem cells: the role of sex steroid receptors
Giovannelli, P., Donato, M. D., Galasso, G., Zazzo, E. D., Medici, N., Bilancio, A., Migliaccio, A., & Castoria, G. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i9.594 · Cited by 36
Modulation of Estrogen Receptor Alpha Activity and Expression During Breast Cancer Progression
Kerdivel, G., Flouriot, G., & Pakdel, F. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-416673-8.00004-6 · Cited by 33
Self-citationSynergism between Genomic and Non Genomic Estrogen Action Mechanisms
Acconcia, F., & Marino, M. (2003) · IUBMB Life · doi:10.1080/1521654031000110172 · Cited by 32
McAnulty, J., & DiFeo, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249486 · Cited by 29
The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs)
Wang, L., & Sharma, A. (2020) · ChemMedChem · doi:10.1002/cmdc.202000473 · Cited by 27
Jiménez-Salazar, J. E., Damián-Ferrara, R., Arteaga, M., Batina, N., & Damián‐Matsumura, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.631007 · Cited by 23
Cottu, P. H., Ring, A. E., Abdel‐Razeq, H., Marchetti, P., Cardoso, F., Bofill, J. S., Martín, M., Menon-Singh, L., Wu, J., & Laurentiis, M. D. (2022) · The Breast · doi:10.1016/j.breast.2022.01.016 · Cited by 22
Jehanno, C., Percevault, F., Boujrad, N., Goff, P. L., Fontaine, C., Arnal, J., Primig, M., Pakdel, F., Michel, D., Métivier, R., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111282 · Cited by 16
Self-citationWang, S., Pfeiffer, R. M., Gierach, G. L., & Falk, R. T. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01365-9 · Cited by 15
Guan, Y., Shen, G., Fang, Q., Xin, Y., Huo, X., Li, J., Zhao, F., Ren, D., Liu, Z., Li, Z., et al. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00814-3 · Cited by 13
Cited by
Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07005-0 · Cited by 13
Metadata
- Authors
- Clusan, L., Ferrière, F., Flouriot, G., & Pakdel, F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-04-06
- Volume
- 24
- Issue
- 7
- Pages
- 6834
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4362667967
- Cited by
- 382
- References
- 150
- FWCI
- 55.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.